Potentiation of anandamide hypotension by the transport inhibitor, AM404

By Calignano A.   La Rana G.   Beltramo M.   Makriyannis A.   Piomelli D.  

European Journal of Pharmacology, Vol. 337, Iss. 1, 1997-10 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 161-174

Bentham Science Publishers

Access to resources Recommend Favorite

URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats

By Hasanein Parisa   Parviz Mohsen   Keshavarz Mansoor   Roohbakhsh Ali  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 6, 2009-06 ,pp. : 432-439

NRC Research Press

Access to resources Recommend Favorite

Fatty Acid Amide Hydrolase Inhibitors - Progress and Potential

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. : 545-558

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors

By Deng Hongfeng  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 961-993

Informa Healthcare

Access to resources Recommend Favorite